Opioid Use in Single Shot Nerve Block vs Continuous Peripheral Nerve Infusion in Anterior Cruciate Ligament (ACL) Repair
Injury of Anterior Cruciate Ligament
About this trial
This is an interventional treatment trial for Injury of Anterior Cruciate Ligament focused on measuring anterior cruciate ligament reconstruction, transplantation allografts, adolescent, nerve block, pain
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiology (ASA) physical status 1 or 2
- Male or female subjects ages 14 to 18 years old at time of procedure
- Patients who undergo an ACL repair using the hamstring autograft at The Children's Hospital of Philadelphia
- Parental/guardian permission (informed consent) and if appropriate, child assent
Exclusion Criteria:
- Parents/patients refusal to the placement of a femoral and/or sciatic nerve block
Contraindications to femoral and/or sciatic nerve block:
- Infection
- Neurologic deficits, including motor and/or sensory deficit of the femoral and sciatic nerves.
- Patients' inability to participate in pain scoring because of developmental delay.
- Performance of an all-epiphyseal ACL repair.
- Allergy to any of the medications used in the study.
- Presence of a coagulopathy
Sites / Locations
- The Children's Hospital Of Philadelphia
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Males Single shot peripheral nerve block
Females Single shot peripheral nerve block
Males Continuous peripheral neural infusion
Females Continuous peripheral neural infusion
a single injection peripheral nerve block (FS/SS) of the femoral and sciatic nerves, Femoral Block - 0.25% bupivacaine (0.5 ml/kg, max 40 ml). The sciatic block will be performed using 0.125% bupivacaine (0.5 ml/kg, max 20 ml).
a single injection peripheral nerve block (FS/SS) of the femoral and sciatic nerves, Femoral Block - 0.25% bupivacaine (0.5 ml/kg, max 40 ml). The sciatic block will be performed using 0.125% bupivacaine (0.5 ml/kg, max 20 ml).
The placement of a femoral continuous peripheral nerve infusion catheter (CPNI) and 0.25% bupivacaine (0.5 ml/kg, max 20 ml) will be injected under ultrasound guidance.
The placement of a femoral continuous peripheral nerve infusion catheter (CPNI) and 0.25% bupivacaine (0.5 ml/kg, max 20 ml) will be injected under ultrasound guidance.